Key Market Indicators
Dane's diabetes medicine market is projected to hit approximately $277 million by 2028, up from around $240 million in 2023. This reflects an average annual growth rate of 2.1%. Since 2002, the market has seen a consistent rise, averaging an annual growth rate of 3.6%. In 2023, Dane ranked sixth in the global market for diabetes medicine sales. Portugal led the rankings with sales also at around $240 million. Italy, Australia, and Croatia followed in the second, third, and fourth positions, respectively.
